Sale of 2,655 shares at $19.5903 per share.
Reporting Person Riley Jennifer · Officer Title Chief Strategy Officer · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0002047607-26-000008 · filed 2026-08-12 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Avalo Therapeutics, Inc. (AVTX)." Disclosed 2026-08-12. https://desqlong.com/cards/0002047607-26-000008-1 (retrieved 2026-09-26).